Nerviano Medical Sciences SRL
Industry
- Biotechnology
- Drug Discovery Technologies
- ADMET
- Drug Discovery Technologies
- Pharmaceuticals
Latest on Nerviano Medical Sciences SRL
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sarepta Obtains Rights To Seven Arrowh
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Coherus Ends TIGIT Pact With Junshi Des
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GSK Pays $66M Up Front For Rights To La
The seven biopharmaceutical firms that priced initial public offerings in the US in September brought the year-to-date total to 54 drug developer IPOs, showing that despite a decline in the average re